• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻内促黄体生成激素释放激素激动剂在子宫平滑肌瘤中的应用。

Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.

作者信息

Maheux R, Lemay A, Merat P

出版信息

Fertil Steril. 1987 Feb;47(2):229-33.

PMID:3102282
Abstract

Nine women harboring uterine leiomyomas have been treated with subcutaneous injections and then with intranasal insufflation of luteinizing hormone-releasing hormone agonist for a total treatment period of 6 months. After initial stimulation, mean serum estradiol progressively decreased and stabilized at 36.8 +/- 4.9 pg/ml for the rest of the treatment period. The volume of uterine leiomyomas has been reduced by an average of 71%. Side effects and hot flushes were less severe and better tolerated than reported after sole subcutaneous administration.

摘要

九名患有子宫平滑肌瘤的女性接受了皮下注射,然后进行了促黄体生成素释放激素激动剂的鼻内吹入,总治疗期为6个月。在初始刺激后,平均血清雌二醇逐渐下降,并在治疗期的剩余时间稳定在36.8 +/- 4.9 pg/ml。子宫平滑肌瘤的体积平均减少了71%。与单独皮下给药后报告的情况相比,副作用和潮热症状较轻,耐受性更好。

相似文献

1
Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.鼻内促黄体生成激素释放激素激动剂在子宫平滑肌瘤中的应用。
Fertil Steril. 1987 Feb;47(2):229-33.
2
Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.促黄体生成素释放激素激动剂与子宫平滑肌瘤:一项初步研究。
Am J Obstet Gynecol. 1985 Aug 15;152(8):1034-8. doi: 10.1016/0002-9378(85)90554-x.
3
Clinical application of a gonadotropin releasing hormone analog (buserelin) in the treatment of uterine leiomyomas.促性腺激素释放激素类似物(布舍瑞林)在子宫肌瘤治疗中的临床应用。
Int J Gynaecol Obstet. 1992 May;38(1):52-3. doi: 10.1016/0020-7292(92)90732-x.
4
[Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].经鼻给予促黄体生成素释放激素激动剂后子宫平滑肌瘤的缩小
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Mar;41(3):365-8.
5
Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.促性腺激素释放激素激动剂治疗围绝经期妇女子宫平滑肌瘤
Clin Obstet Gynecol. 1993 Sep;36(3):660-7. doi: 10.1097/00003081-199309000-00022.
6
Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.迈向非手术去除子宫肌瘤:在黄体期开始皮下输注促黄体生成素释放激素激动剂。
J Clin Endocrinol Metab. 1986 Sep;63(3):619-25. doi: 10.1210/jcem-63-3-619.
7
Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.在使用促黄体生成素释放激素激动剂治疗子宫肌瘤期间,与剂量相关的急性促黄体生成素反应抑制。
Am J Obstet Gynecol. 1988 Feb;158(2):361-4. doi: 10.1016/0002-9378(88)90155-x.
8
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.促黄体生成激素释放激素类似物治疗子宫肌瘤:对经鼻给予布舍瑞林和每月皮下注射戈舍瑞林作为长效注射剂所获结果的分析。
Eur J Obstet Gynecol Reprod Biol. 1990 Oct;37(1):63-9. doi: 10.1016/0028-2243(90)90096-j.
9
Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
Fertil Steril. 1990 Dec;54(6):1032-8. doi: 10.1016/s0015-0282(16)54001-1.
10
Conservative management for perimenopausal women with uterine leiomyomas using Chinese herbal medicines and synthetic analogs of gonadotropin-releasing hormone.
In Vivo. 1998 May-Jun;12(3):333-7.

引用本文的文献

1
A benefit-risk assessment of medical treatment for uterine leiomyomas.子宫肌瘤医学治疗的获益-风险评估
Drug Saf. 2002;25(11):759-79. doi: 10.2165/00002018-200225110-00002.
2
GnRH agonists and antagonists. Current clinical status.促性腺激素释放激素激动剂和拮抗剂。当前临床状况。
Drugs. 1988 Jan;35(1):63-82. doi: 10.2165/00003495-198835010-00004.
3
Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.促黄体生成激素释放激素及其类似物:生物学特性与临床应用综述
J Endocrinol Invest. 1988 Jul-Aug;11(7):535-57. doi: 10.1007/BF03350179.
4
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.布舍瑞林。对其药效学和药代动力学特性以及临床概况的综述。
Drugs. 1990 Mar;39(3):399-437. doi: 10.2165/00003495-199039030-00007.
5
Shrinkage of uterine fibroids by preoperative LHRH analogue injection.术前注射促性腺激素释放激素类似物使子宫肌瘤缩小。
Ulster Med J. 1992 Apr;61(1):51-5.